To further characterize the lung adenocarcinomas in Med23‐deficient mice, we performed whole exome sequencing and found that Med23−/− lung adenocarcinomas displayed increased single nucleotide polymorphism (SNP) mutation rate compared with those of Med23−/− normal tissue controls (Figure2A,B). The gene discussed is MED23; the disease is lung adenocarcinoma.